| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 32,630 | |||
| Accounts receivable, net | 33,225 | |||
| Inventories | 10,100 | |||
| Prepaid expenses and other current assets | 5,154 | |||
| Total current assets | 81,109 | |||
| Property and equipment, gross | 1,235 | |||
| Less accumulated depreciation and amortization | 735 | |||
| Property and equipment, net | 500 | |||
| Operating lease right-of-use assets | 1,010 | |||
| Intangible assets, net | 41,430 | |||
| Other non-current assets | 939 | |||
| Total non-current assets | 43,879 | |||
| Total assets | 124,988 | |||
| Accounts payable | 12,342 | |||
| Accrued liabilities | 36,700 | |||
| Revolving credit facility | 14,873 | |||
| Current portion of debt-Debt Excluding Credit Facility | 1,857 | |||
| Other current liabilities | 221 | |||
| Total current liabilities | 65,993 | |||
| Debt, net of current portion | 10,447 | |||
| Derivative warrant liabilities | 20,424 | |||
| Other non-current liabilities | 4,953 | |||
| Total non-current liabilities | 35,824 | |||
| Common stock, par value 0.0001 200,000,000 shares authorized 9,911,913 and 8,976,913 shares issued and outstanding, respectively | 1 | |||
| Additional paid-in capital | 354,740 | |||
| Accumulated deficit | -331,570 | |||
| Total stockholders equity | 23,171 | |||
| Total liabilities and stockholders equity | 124,988 | |||
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)